115 related articles for article (PubMed ID: 31744787)
1. Detection of meningioma in a patient with mild cognitive impairment assessed by
Jiménez-Bonilla JF; Quirce R; De Arcocha-Torres M; Martínez-Rodríguez I; Martínez-Amador N; Banzo I
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):106-107. PubMed ID: 31744787
[No Abstract] [Full Text] [Related]
2. Sphenoid wing meningioma behavior on 11C-PiB and 18F-FDG PET.
Chaves H; Bergamo Y; Paz S; Sanchez F; Vazquez S
Clin Nucl Med; 2015 Jan; 40(1):e81-2. PubMed ID: 24662661
[TBL] [Abstract][Full Text] [Related]
3. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
[TBL] [Abstract][Full Text] [Related]
5. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
Tomura N; Saginoya T; Goto H
J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
[TBL] [Abstract][Full Text] [Related]
6. Incidental finding of meningioma on C11-PIB PET.
Kim HY; Kim J; Lee JH
Clin Nucl Med; 2012 Feb; 37(2):e36-7. PubMed ID: 22228363
[TBL] [Abstract][Full Text] [Related]
7. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors.
Johnson DR; Hunt CH; Nathan MA; Parisi JE; Boeve BF; Murray ME; Knopman DS; Jack CR; Petersen RC; Lowe VJ; Johnson GB
J Neurooncol; 2018 Jan; 136(2):373-378. PubMed ID: 29116483
[TBL] [Abstract][Full Text] [Related]
8. A case report of primary pulmonary meningioma masquerading as lung metastasis in a patient with rectal carcinoma: role of
Jiang M; Chen P; Huang R; Zhang J; Zheng J
J Cardiothorac Surg; 2021 May; 16(1):153. PubMed ID: 34051819
[TBL] [Abstract][Full Text] [Related]
9. The aggressiveness and extent of meningioma imaged by combined fluorine-18 FDG and positron emission tomography.
Wong CO; Bleza MV; Dworkin HJ
Clin Nucl Med; 2000 Sep; 25(9):736. PubMed ID: 10983771
[No Abstract] [Full Text] [Related]
10. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced meningioma evaluated with positron emission tomography with fludeoxyglucose F 18.
Kado H; Ogawa T; Hatazawa J; Iwase M; Kanno I; Okudera T; Uemura K
AJNR Am J Neuroradiol; 1996 May; 17(5):937-8. PubMed ID: 8733970
[TBL] [Abstract][Full Text] [Related]
12. Parapharyngeal meningioma extending from the intracranial space evaluated by FDG PET.
Kado H; Ogawa T; Okudera T; Kanno I; Hatazawa J; Uemura K
J Nucl Med; 1998 Feb; 39(2):302-4. PubMed ID: 9476940
[TBL] [Abstract][Full Text] [Related]
13. F-18 fluorodeoxyglucose positron emission tomography in a transitional meningioma.
Amemiya S; Aoki S; Akahane M; Ohtomo K
Clin Nucl Med; 2009 Jul; 34(7):462-3. PubMed ID: 19542958
[No Abstract] [Full Text] [Related]
14. FDG PET/CT of Benign Psammomatous Meningioma Effacing the Medulla.
Chuang TL; Chen JC; Chen YR; Wang YF
Clin Nucl Med; 2021 Mar; 46(3):252-254. PubMed ID: 33351510
[TBL] [Abstract][Full Text] [Related]
15. Complementary Molecular and Metabolic Characterization of Meningiomas With DOTATATE and FDG-PET: Advancing Treatment Planning and Prognostication.
Dressen MS; Muthukrishnan A; Tragon TR; Lieberman FS; Mountz JM
Clin Nucl Med; 2019 Jan; 44(1):e26-e27. PubMed ID: 30371576
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
[TBL] [Abstract][Full Text] [Related]
17. Pittsburgh Compound-B Uptake in Meningioma With Histopathologic Correlation.
Doi S; Kashiwagi N; Satou T; Kaida H; Ishi K
Clin Nucl Med; 2019 Jul; 44(7):587-588. PubMed ID: 31135517
[TBL] [Abstract][Full Text] [Related]
18. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
[TBL] [Abstract][Full Text] [Related]
19. Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
Varghese B; Velez E; Desai B; Jadvar H
Clin Nucl Med; 2018 Jul; 43(7):e245-e246. PubMed ID: 29742600
[TBL] [Abstract][Full Text] [Related]
20. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
